These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3821375)

  • 21. Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro.
    Asanuma M; Miyazaki I; Diaz-Corrales FJ; Shimizu M; Tanaka K; Ogawa N
    Neurol Res; 2005 Jul; 27(5):533-9. PubMed ID: 15978181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extrapyramidal motor symptoms versus striatal infarction volume after focal ischemia in mongolian gerbils.
    Ishibashi S; Kuroiwa T; Katsumata N; Yuan SL; Endo S; Mizusawa H
    Neuroscience; 2004; 127(2):269-75. PubMed ID: 15262318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviour.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Biochem Pharmacol; 1995 May; 49(9):1185-93. PubMed ID: 7763300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D₁ and D₂ receptor subtypes functional regulation in corpus striatum of unilateral rotenone lesioned Parkinson's rat model: effect of serotonin, dopamine and norepinephrine.
    Paul J; Nandhu MS; Kuruvilla KP; Paulose CS
    Neurol Res; 2010 Nov; 32(9):918-24. PubMed ID: 20887679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model.
    Willis GL; Kelly AM; Kennedy GA
    Behav Brain Res; 2008 Nov; 193(1):37-47. PubMed ID: 18547659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.
    Nash JE; Brotchie JM
    Mov Disord; 2002 May; 17(3):455-66. PubMed ID: 12112191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
    Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
    Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed emergence of striatal dopaminergic hyperactivity after anterolateral ischemic cortical lesions in humans; evidence from turning behavior.
    Bracha HS; Lyden PD; Khansarinia S
    Biol Psychiatry; 1989 Feb; 25(3):265-74. PubMed ID: 2914151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism.
    Senthilkumar KS; Saravanan KS; Chandra G; Sindhu KM; Jayakrishnan A; Mohanakumar KP
    Behav Brain Res; 2007 Nov; 184(1):11-8. PubMed ID: 17765334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons.
    Frau L; Morelli M; Simola N
    Exp Neurol; 2013 Sep; 247():663-72. PubMed ID: 23499830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which is responsible for circling behavior in rats, locus coeruleus or dorsolateral pontine tegmentum?
    Matsuoka S; Shima F; Suzuki M; Kitamura K; Kato M
    Brain Res; 1986 Nov; 398(2):253-8. PubMed ID: 3801902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral/neurophysiological investigation of effects of combining a quinolinic acid entopeduncular lesion with a fetal mesencephalic tissue transplant in striatum of the 6-OHDA hemilesioned rat.
    Olds ME; Jacques DB; Kpoyov O
    Synapse; 2003 Jul; 49(1):1-11. PubMed ID: 12710010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
    Ogura T; Ogata M; Akita H; Jitsuki S; Akiba L; Noda K; Hoka S; Saji M
    Neurosci Res; 2005 Mar; 51(3):299-308. PubMed ID: 15710494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral imbalance in striatal DA-uptake controls rotation behavior.
    Gordon I; Rehavi M; Mintz M
    Brain Res; 1994 May; 646(2):207-10. PubMed ID: 8069665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scoliosis in rats with experimentally-induced hemiparkinsonism: dependence upon striatal dopamine denervation.
    Herrera-Marschitz M; Utsumi H; Ungerstedt U
    J Neurol Neurosurg Psychiatry; 1990 Jan; 53(1):39-43. PubMed ID: 2303830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sprouting of dopaminergic fibers from spared mesencephalic dopamine neurons in the unilateral partial lesioned rat.
    Hansen JT; Sakai K; Greenamyre JT; Moran S
    Brain Res; 1995 Jan; 670(2):197-204. PubMed ID: 7743186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The aging striatal dopamine function.
    Darbin O
    Parkinsonism Relat Disord; 2012 Jun; 18(5):426-32. PubMed ID: 22176812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
    Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
    Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.